Education
About Us
Working with TipRanks
Follow Us
Sanofi (FR:SAN)
:SAN
Total Valuation
Sanofi has a market cap or net worth of €94.14B. The enterprise value is €110.54B.
Market Cap€94.14B
Enterprise Value€110.54B
Share Statistics
Sanofi has 1,219,502,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,219,502,200
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Sanofi’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 11.43%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)11.43%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee526.39K
Profits Per Employee59.59K
Employee Count82,878
Asset Turnover0.34
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sanofi is 18.2. Sanofi’s PEG ratio is 0.28.
PE Ratio18.2
PS Ratio2.31
PB Ratio1.41
Price to Fair Value1.41
Price to FCF11.23
Price to Operating Cash Flow4.74
PEG Ratio0.28
Income Statement
In the last 12 months, Sanofi had revenue of 43.63B and earned 7.81B in profits. Earnings per share was 6.40.
Revenue43.63B
Gross Profit30.58B
Operating Income14.25B
Pretax Income6.02B
Net Income7.81B
EBITDA6.74B
Earnings Per Share (EPS)6.40
Cash Flow
In the last 12 months, operating cash flow was 12.84B and capital expenditures -1.76B, giving a free cash flow of 11.08B billion.
Operating Cash Flow12.84B
Free Cash Flow11.08B
Free Cash Flow per Share9.09
Dividends & Yields
Sanofi pays an annual dividend of €3.92, resulting in a dividend yield of 4.77%
Dividend Per Share€3.92
Dividend Yield4.77%
Payout Ratio54.52%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.87
52-Week Price Change-19.63%
50-Day Moving Average80.82
200-Day Moving Average83.93
Relative Strength Index (RSI)48.69
Average Volume (3m)1.95M
Important Dates
Sanofi upcoming earnings date is Apr 23, 2026, Before Open (Confirmed).
Last Earnings DateJan 29, 2026
Next Earnings DateApr 23, 2026
Ex-Dividend Date―
Financial Position
Sanofi as a current ratio of 1.09, with Debt / Equity ratio of 30.54%
Current Ratio1.09
Quick Ratio1.09
Debt to Market Cap0.20
Net Debt to EBITDA2.10
Interest Coverage Ratio25.31
Taxes
In the past 12 months, Sanofi has paid 1.04B in taxes.
Income Tax1.04B
Effective Tax Rate0.17
Enterprise Valuation
Sanofi EV to EBITDA ratio is 17.08, with an EV/FCF ratio of 12.80.
EV to Sales2.64
EV to EBITDA17.08
EV to Free Cash Flow12.80
EV to Operating Cash Flow10.71
Balance Sheet
Sanofi has €7.66B in cash and marketable securities with €21.80B in debt, giving a net cash position of -€14.14B billion.
Cash & Marketable Securities€7.66B
Total Debt€21.80B
Net Cash-€14.14B
Net Cash Per Share-€11.59
Tangible Book Value Per Share€3.40
Margins
Gross margin is 71.74%, with operating margin of 32.67%, and net profit margin of 17.91%.
Gross Margin71.74%
Operating Margin32.67%
Pretax Margin13.80%
Net Profit Margin17.91%
EBITDA Margin15.44%
EBIT Margin15.44%
Analyst Forecast
The average price target for Sanofi is €95.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€95.67
Price Target Upside20.21% Upside
Analyst ConsensusModerate Buy
Analyst Count13
Revenue Growth Forecast-9.82%
EPS Growth Forecast119.10%